Neoplasms, Germ Cell and Embryonal
"Neoplasms, Germ Cell and Embryonal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.
Descriptor ID |
D009373
|
MeSH Number(s) |
C04.557.465
|
Concept/Terms |
Neoplasms, Germ Cell- Neoplasms, Germ Cell
- Germ Cell Tumor
- Germ Cell Tumors
- Tumor, Germ Cell
- Tumors, Germ Cell
- Germ Cell Neoplasms
Cancer, Embryonal- Cancer, Embryonal
- Cancers, Embryonal
- Embryonal Cancer
- Embryonal Cancers
Germ Cell Cancer- Germ Cell Cancer
- Cancer, Germ Cell
- Cancers, Germ Cell
- Germ Cell Cancers
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Germ Cell and Embryonal".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Germ Cell and Embryonal".
This graph shows the total number of publications written about "Neoplasms, Germ Cell and Embryonal" by people in this website by year, and whether "Neoplasms, Germ Cell and Embryonal" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 | 2009 | 2 | 0 | 2 | 2011 | 2 | 0 | 2 | 2012 | 3 | 0 | 3 | 2013 | 3 | 0 | 3 | 2014 | 1 | 1 | 2 | 2015 | 1 | 0 | 1 | 2016 | 2 | 0 | 2 | 2018 | 1 | 0 | 1 | 2019 | 2 | 0 | 2 | 2020 | 2 | 0 | 2 | 2021 | 6 | 0 | 6 | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasms, Germ Cell and Embryonal" by people in Profiles.
-
Hart M, Anderson-Mellies A, Beltrami A, Gilani A, Green AL. Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups. J Neurooncol. 2022 Apr; 157(2):333-344.
-
Barragán-Carrillo R, Mateos-Corella S, Ortiz-Hidalgo C, Izquierdo-Echavarri E, Castillejos-Molina R, Angel M, Barragan-Arteaga I, Flaig T, Bourlon MT. Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor. Oncology (Williston Park). 2021 12 17; 35(12):816-819.
-
Myklebust MP, Thor A, Rosenlund B, Gjengstø P, Karlsdottir Á, Brydøy M, Bercea BS, Olsen C, Johnson I, Berg MI, Langberg CW, Andreassen KE, Kjellman A, Haugnes HS, Dahl O. Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study. Sci Rep. 2021 08 02; 11(1):15582.
-
Green DB, La Rosa FG, Craig PG, Khani F, Lam ET. Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors. Korean J Radiol. 2021 10; 22(10):1650-1657.
-
Jarvis H, Cost NG, Saltzman AF. Testicular tumors in the pediatric patient. Semin Pediatr Surg. 2021 Aug; 30(4):151079.
-
Duarte C, Gilbert DM, Sheridan AD, La Rosa FG, McCarter M, Cost NG, Emmons S, Lam ET. Spontaneous regression of an extragonadal seminomatous germ cell tumor. Cancer Treat Res Commun. 2021; 28:100383.
-
Gerdtsson A, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Sagstuen Haugnes H, Engen Andreassen K, Melsen Larsen S, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A. Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group. Eur Urol Oncol. 2022 04; 5(2):235-243.
-
Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 04; 16(4):e1008642.
-
Nasioudis D, Mastroyannis SA, Latif NA, Ko EM. Trends in the surgical management of malignant ovarian germcell tumors. Gynecol Oncol. 2020 04; 157(1):89-93.
-
Sin-Chan P, Mumal I, Suwal T, Ho B, Fan X, Singh I, Du Y, Lu M, Patel N, Torchia J, Popovski D, Fouladi M, Guilhamon P, Hansford JR, Leary S, Hoffman LM, Mulcahy Levy JM, Lassaletta A, Solano-Paez P, Rivas E, Reddy A, Gillespie GY, Gupta N, Van Meter TE, Nakamura H, Wong TT, Ra YS, Kim SK, Massimi L, Grundy RG, Fangusaro J, Johnston D, Chan J, Lafay-Cousin L, Hwang EI, Wang Y, Catchpoole D, Michaud J, Ellezam B, Ramanujachar R, Lindsay H, Taylor MD, Hawkins CE, Bouffet E, Jabado N, Singh SK, Kleinman CL, Barsyte-Lovejoy D, Li XN, Dirks PB, Lin CY, Mack SC, Rich JN, Huang A. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor. Cancer Cell. 2019 07 08; 36(1):51-67.e7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|